ArticlePediatric nephrology (Berlin, Germany)2019

An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis.

Winnie Y Sohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.